Artiva Biotherapeutics (ARTV) Interest & Investment Income (2023 - 2026)
Artiva Biotherapeutics (ARTV) reported Interest & Investment Income of $912000.0 for Q1 2026, down 51.07% year-over-year from $1.9 million in Q1 2025, and down 21.51% quarter-over-quarter from $1.2 million in Q4 2025.
Artiva Biotherapeutics (ARTV) Interest & Investment Income (2023 - 2026) Analysis & Trends
Artiva Biotherapeutics (ARTV) has 4 years of Interest & Investment Income data on file, last reported at $912000.0 in Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $912000.0, down 51.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.0 million (down 23.71% YoY), and the FY2025 annual result was $6.0 million, up 11.4% from the prior year.
- Interest & Investment Income slipped to $912000.0 in Q1 2026 per ARTV's latest filing, from $1.2 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at $2.2 million in Q4 2024 and troughed at $418000.0 in Q3 2023.
- A 4-year average of $1.1 million and a median of $1.0 million in 2025 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2024 and 2026: Interest & Investment Income soared 341.63% in 2024, then plunged 51.07% in 2026.
- A 4-year view of Interest & Investment Income shows it stood at $583000.0 in 2023, then soared by 273.41% to $2.2 million in 2024, then plunged by 46.62% to $1.2 million in 2025, then declined by 21.51% to $912000.0 in 2026.
- Business Quant data shows ARTV's Interest & Investment Income at $912000.0 in Q1 2026, $1.2 million in Q4 2025, and $1.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Artiva Biotherapeutics | 241.85 Mn | 241.85 Mn | - | 912,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 912,000.00 |
| Dec 31, 2025 | 1.16 Mn |
| Sep 30, 2025 | 1.37 Mn |
| Jun 30, 2025 | 1.56 Mn |
| Mar 31, 2025 | 1.86 Mn |
| Dec 31, 2024 | 2.18 Mn |
| Sep 30, 2024 | 1.85 Mn |
| Jun 30, 2024 | 676,000.00 |
| Mar 31, 2024 | 650,000.00 |
| Dec 31, 2023 | 583,000.00 |
| Sep 30, 2023 | 418,000.00 |
| Jun 30, 2023 | 509,000.00 |